Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2023.2196010
Abstract: ABSTRACT Introduction For a long time, metformin has been the first-line treatment for glycemic control in type 2 diabetes; however, the results of recent cardiovascular outcome trials of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide… read more here.
Keywords: cardiovascular benefit; metformin evidence; preclinical clinical; clinical studies ... See more keywords